RT Journal Article SR Electronic T1 Poor inhibitory control and stress as risk-factors for alcohol (mis)use during the COVID-19 pandemic in the UK: a national cross-sectional study across four generations JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.09.24.20197293 DO 10.1101/2020.09.24.20197293 A1 James M. Clay A1 Lorenzo D. Stafford A1 Matthew O. Parker YR 2020 UL http://medrxiv.org/content/early/2020/09/25/2020.09.24.20197293.abstract AB Background The impact COVID-19 on the UK population’s alcohol intake is unknown. We assessed change in alcohol-use and hazardous drinking during the first lockdown, and tested the hypothesis that variation would be predicted by stress and inhibitory-control.Methods We interrogated cross-sectional data from the first sweep of the COVID-19 longitudinal survey, comprising 4 national cohorts (13 453 respondents, 19-62 years). Respondents self-reported their alcohol use, stress, and inhibitory control. We regressed change in drinking and alcohol misuse on stress and inhibitory control, adjusting for covariates to account for demographics.Findings 29·08% 30-year-olds increased alcohol use post-COVID-19. Stress was a major contributing factor to increased alcohol use in 30-year olds (adjusted OR 3·92, 95% CI 1·17 - 13·15), as was inhibitory control in 19-year-olds (adjusted OR 1·14, 95% CI 1·05 - 1·23), 30-year-olds (adjusted OR 1·18, 95% CI 1.05 - 1.33) and 50-year-olds (adjusted OR 1·06, 95% CI 1·01 - 1·12). We identified several interactions between stress and inhibitory control in all age groups, suggesting a complex age-specific relationship between the risk factors and alcohol use and misuse during the pandemic.Interpretation In the UK, alcohol use increased in up to 30% of the population during COVID-19, resulting from a combination of factors including poor inhibitory control and stress. It is critical in future lockdowns that clinicians and public health officials are aware of the challenges faced by different age groups, and prioritise and personalise interventions and prevention measures appropriately.Funding ESRC, Foundation for Liver Research.Evidence before the study We searched PubMed, Web of Science, EBSCO Discovery, bioRxiv, medRxiv, and PsyArXiv for articles published between Jan 1, 2020 and Sep 1, 2020, with the following keywords: “covid-19”, “coronavirus”, and “alcohol”. We prioritised the selection of references based on relevance, importance, opportunity for further reading, and whether the work had been peer-reviewed. There have been several published articles that address the issue of alcohol use and misuse during COVID– 19, including a number of editorials and some limited empirical work. There were no nationally representative studies about alcohol use in the UK. In addition, all of the studies identified simply reported figures of those using alcohol during the pandemic, and to the best of our knowledge, none covered risk-factors for alcohol misuse.Added value of this study Using data from the COVID-19 national longitudinal survey (first sweep), comprising data from 18 000 people across five national cohorts (aged 19-74), we tested the hypothesis that people who reported higher levels of stress, and who self-reported low impulse-control, would show higher rates of alcohol use/misuse during the pandemic lockdown. First, we show the proportion of adults across the UK that are drinking more during the pandemic, and how this differs by age and gender. Second, we show that while higher levels of stress were associated with higher levels of alcohol intake in some (e.g., 30-year-olds), we found that the relationship was complex and multifaceted. Stress-induced alcohol use and misuse was dependent on age and personality characteristics, with low impulse-control predictive of higher levels of alcohol consumption in 19-, 30- and 50-year-olds, and several stress x personality interactions.Implications of all the available evidence Stress, as well as poor inhibitory control, were risk factors for the susceptibility to increased alcohol intake and hazardous drinking during the early stages of the COVID-19 pandemic and lockdown. The government, healthcare professionals, and the global media should consider the impact of change of lifestyle and stress that might impact on alcohol consumption among at-risk individuals during any future lockdowns. Similarly, additional support for those that may go on to develop an alcohol use disorder or relapse needs to be put in place.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJMC is funded by an ESRC Doctoral Training Partnership grant. MOP receives funding from the Foundation for Liver Research. The funders had no role in study design, data analysis, data interpretation, writing of the report, or the decision to submit for publication. The UCL Centre for Longitudinal Studies, who administered the survey, played no role in the analysis of the data, preparation of the manuscript, or decision to submit the manuscript for publication. All authors had full access to all data in the study. All authors were responsible for the decision to submit for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The data used in this work were from the UK Data Service. The registration for the access to the data from UK Data Service was done via University of Portsmouth. Access to the data was given by UK Data Service with the Project Number: 197137. As a secondary analysis was carried out, full ethical review was not required. Thus, the University of Portsmouth Ethics Screening Tool was used for assessment (reference number: ETHICS-10155). All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in this study are available from the UK Data Service Website (https://ukdataservice.ac.uk/) under the "Safeguarded" data access policy. The primary dataset used is referenced under study number 8658. Ethnicity data associated with the MCS, Next Steps, BCS70, and NCDS cohorts are referenced under study numbers 6073, 5545, 5558, and 5565 respectively. All analysis code is available on the Open Science Framework website (https://osf.io/wf2rj/). https://osf.io/wf2rj/